Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
Authors
Keywords
-
Journal
NATURAL PRODUCT REPORTS
Volume 31, Issue 7, Pages 924-939
Publisher
Royal Society of Chemistry (RSC)
Online
2014-05-02
DOI
10.1039/c4np00006d
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex
- (2013) Heather Sadlish et al. ACS Chemical Biology
- Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
- (2013) Frédéric Thuaud et al. CHEMISTRY & BIOLOGY
- The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints
- (2013) Jennifer Neumann et al. INTERNATIONAL JOURNAL OF CANCER
- Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
- (2013) Houda Alachkar et al. Journal of Hematology & Oncology
- Bioactive Flavaglines and Other Constituents Isolated from Aglaia perviridis
- (2013) Li Pan et al. JOURNAL OF NATURAL PRODUCTS
- Synthesis of Biotinylated Episilvestrol: Highly Selective Targeting of the Translation Factors eIF4AI/II
- (2013) Jennifer M. Chambers et al. ORGANIC LETTERS
- Prohibitin, an essential protein for Colorado potato beetle larval viability, is relevant to Bacillus thuringiensis Cry3Aa toxicity
- (2013) Camila Ochoa-Campuzano et al. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
- Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
- (2013) Takayuki Kogure et al. PLoS One
- Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation
- (2013) H. A. Meijer et al. SCIENCE
- Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State
- (2013) S. Santagata et al. SCIENCE
- The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
- (2012) Gernot Polier et al. CHEMISTRY & BIOLOGY
- Dual Targeting of the Cyclin/Rb/E2F and Mitochondrial Pathways in Mantle Cell Lymphoma with the Translation Inhibitor Silvestrol
- (2012) L. Alinari et al. CLINICAL CANCER RESEARCH
- Flavaglines as Potent Anticancer and Cytoprotective Agents
- (2012) Nigel Ribeiro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthetic Silvestrol Analogues as Potent and Selective Protein Synthesis Inhibitors
- (2012) Tao Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Total Synthesis of (±)-Rocaglamide via Oxidation-Initiated Nazarov Cyclization
- (2012) John A. Malona et al. JOURNAL OF ORGANIC CHEMISTRY
- Formal Synthesis of (±)-Methyl Rocaglate Using an Unprecedented Acetyl Bromide Mediated Nazarov Reaction
- (2012) Philip Magnus et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Enantioselective Photocycloaddition of 3-Hydroxyflavones: Total Syntheses and Absolute Configuration Assignments of (+)-Ponapensin and (+)-Elliptifoline
- (2012) Neil J. Lajkiewicz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein
- (2012) C Jin et al. ONCOGENE
- Two new rocaglamide derivatives from twigs of Aglaia odorata var. microphyllina
- (2012) Shuai Liu et al. Phytochemistry Letters
- A cellular response linking eIF4AI activity to eIF4AII transcription
- (2012) G. Galicia-Vazquez et al. RNA
- Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor
- (2012) L M Lindqvist et al. Cell Death & Disease
- Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells
- (2011) Sneha V. Gupta et al. AAPS Journal
- Characterization of Silvestrol Pharmacokinetics in Mice Using Liquid Chromatography–Tandem Mass Spectrometry
- (2011) U. V. R. Vijaya Saradhi et al. AAPS Journal
- Recent advances in the biology and chemistry of the flavaglines
- (2011) Nigel Ribeiro et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeted cancer therapy
- (2011) Jonathan H. Schatz et al. CELL CYCLE
- Synthesis of Rocaglamide Hydroxamates and Related Compounds as Eukaryotic Translation Inhibitors: Synthetic and Biological Studies
- (2011) Christina M. Rodrigo et al. JOURNAL OF MEDICINAL CHEMISTRY
- The biological and therapeutic relevance of mRNA translation in cancer
- (2011) Sarah P. Blagden et al. Nature Reviews Clinical Oncology
- mRNA helicases: the tacticians of translational control
- (2011) Armen Parsyan et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27
- (2011) Yohann Bernard et al. PLoS One
- Biomimetic Photocycloaddition of 3-Hydroxyflavones: Synthesis and Evaluation of Rocaglate Derivatives as Inhibitors of Eukaryotic Translation
- (2010) Stéphane P. Roche et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression
- (2010) M Bleumink et al. CELL DEATH AND DIFFERENTIATION
- Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma
- (2010) David M. Lucas et al. CURRENT DRUG TARGETS
- The role of prohibitin in cell signaling
- (2010) Suresh Mishra et al. FEBS Journal
- Novel Flavaglines Displaying Improved Cytotoxicity
- (2010) Frédéric Thuaud et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isolation and Characterization of Minor Analogues of Silvestrol and Other Constituents from a Large-Scale Re-collection ofAglaia foveolata
- (2010) Li Pan et al. JOURNAL OF NATURAL PRODUCTS
- Constituents of Amoora cucullata with TRAIL resistance-overcoming activity
- (2010) Firoj Ahmed et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
- (2009) David M. Lucas et al. BLOOD
- Inhibiting the transcription factor HSF1 as an anticancer strategy
- (2009) Luke Whitesell et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Synthetic Analogue of Rocaglaol Displays a Potent and Selective Cytotoxicity in Cancer Cells: Involvement of Apoptosis Inducing Factor and Caspase-12
- (2009) Frédéric Thuaud et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nazarov Cyclization Initiated by Peracid Oxidation: The Total Synthesis of (±)-Rocaglamide
- (2009) John A. Malona et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells
- (2009) Regina Cencic et al. LEUKEMIA RESEARCH
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
- (2009) Regina Cencic et al. PLoS One
- Amide-esters from Aglaia tenuicaulis – First representatives of a class of compounds structurally related to bisamides and flavaglines
- (2007) Harald Greger et al. PHYTOCHEMISTRY
- Flavaglines and triterpenoids from the leaves of Aglaia forbesii
- (2007) Nantiya Joycharat et al. PHYTOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation